AVEO Oncology to Present at the Deutsche Bank 2012 dbAccess BioFEST Conference

  AVEO Oncology to Present at the Deutsche Bank 2012 dbAccess BioFEST
  Conference

Business Wire

CAMBRIDGE, Mass. -- November 26, 2012

AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief
financial officer, is scheduled to present at the Deutsche Bank 2012 dbAccess
BioFEST Conference on Monday, December 3, 2012 at 4:35 p.m. (ET) in Boston.

A live webcast of AVEO’s presentation can be accessed by visiting the
investors section of the company’s website at investor.aveooncology.com. A
replay of the webcast will be archived on the AVEO website for two weeks
following the presentation.

About AVEO

AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to
discovering, developing and commercializing targeted therapies to impact
patients’ lives. AVEO’s proprietary Human Response Platform^TM provides the
company unique insights into cancer biology and is being leveraged in the
discovery and clinical development of its cancer therapeutics. For more
information, please visit the company’s website at www.aveooncology.com.

Contact:

Investor:
AVEO Oncology
Monique Allaire, 617-299-5810
or
Media:
AVEO Oncology
Rob Kloppenburg, 617-930-5595